Home/Filings/4/0001347535-25-000005
4//SEC Filing

DIVITA CHARLES III 4

Accession 0001347535-25-000005

CIK 0001477449other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 4:04 PM ET

Size

8.6 KB

Accession

0001347535-25-000005

Insider Transaction Report

Form 4
Period: 2025-09-10
DIVITA CHARLES III
DirectorCHIEF EXECUTIVE OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2025-09-10+39,160195,801 total
  • Sale

    Common Stock

    2025-09-11$7.59/sh16,787$127,435179,014 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-09-1039,160274,123 total
    Common Stock (39,160 underlying)
Footnotes (3)
  • [F1]Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
  • [F2]Shares sold to cover the tax withholding obligation in respect of vesting of the reporting person's restricted stock unit awards.
  • [F3]On June 10, 2024, the reporting person was granted 469,924 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter.

Issuer

Teladoc Health, Inc.

CIK 0001477449

Entity typeother

Related Parties

1
  • filerCIK 0001347535

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:04 PM ET
Size
8.6 KB